Press Resease

Embolization Particle Market - Global Industry Analysis

Embolization Particle Market by Particle Type (Microspheres, Particles, Drug Eluting Beads, and Radio Embolic Microspheres), by Application (Trauma Embolization, Liver Tumor Embolization, Prostatic Artery Embolization, Uterine Fibroid Embolization, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 27-Dec-2018 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3677 Status : Published

Global embolization particle market expected to generate around USD 2577 million by 2024, growing at a CAGR of around 12.1% between 2018 and 2024. There increased prevalence of cancers and tumors is likely to drive the embolization particle market over the forecast time period.

Description

The report covers a forecast and an analysis of the embolization particle market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based revenue (USD Million). The study includes drivers and restraints for the embolization particle market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the embolization particle market on a global level.

In order to give the users of this report a comprehensive view of the embolization particle market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Embolization Particle Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. 

The study provides a decisive view of the embolization particle market by segmenting the market based on particle type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on particles type, the embolization particle market is segmented into microspheres, particles, drug-eluting beads (DEBs), and radio-embolic microspheres. Based on application, the embolization particle market is segmented into trauma embolization, liver tumor embolization, prostatic artery embolization, uterine fibroid embolization, and others.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries, including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some major players of the embolization particle market include Sirtex Medical Limited, Boston Scientific Corporation, Merit Medical Systems, BTG International Ltd., Cook Medical, and Interface BIOmaterials, among others.

This report segments the global embolization particle market as follows:

Global Embolization Particle Market: Particle Type Analysis

  • Microspheres
  • Particles
  • Drug-Eluting Beads (DEBs)
  • Radio-Embolic Microspheres

Global Embolization Particle Market: Application Analysis

  • Trauma Embolization
  • Liver Tumor Embolization
  • Prostatic Artery Embolization
  • Uterine Fibroid Embolization
  • Others

Global Embolization Particle Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Embolization Particle Market, 2015 - 2024 (USD Million)
    • 2.2. Global Embolization Particle Market: Snapshot
  •  
  • Chapter 3. Embolization Particle Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Embolization Particle Market drivers: Impact analysis
      • 3.2.2. Increased prevalence of Cancer
      • 3.2.3. Technological advancement
    • 3.3. Market Restraints
      • 3.3.1. Lack of skilled interventional radiologist
    • 3.4. Opportunities
      • 3.4.1. New product launches
    • 3.5. Porter's Five Forces Analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Particle Type
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Embolization Particle Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Embolization Particle Market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Particle TypeLaunch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Embolization Particle Market - Particle Type Analysis
    • 5.1. Global Embolization Particle Market: Particle Type overview
      • 5.1.1. Global Embolization Particle Market revenue share, by Particle Type, 2015 and 2024(USD Million)
    • 5.2. Microspheres
      • 5.2.1. Global Microspheres market, 2015 - 2024(USD Million)
    • 5.3. Particles
      • 5.3.1. Global Particles market, 2015 - 2024(USD Million)
    • 5.4. Drug-Eluting Beads (DEBs)
      • 5.4.1. Global Drug-Eluting Beads (DEBs) market, 2015 - 2024(USD Million)
    • 5.5. Radio-Embolic Microspheres
      • 5.5.1. Global Radio-Embolic Microspheresmarket, 2015 - 2024(USD Million)
  •  
  • Chapter 6. Global Embolization Particle Market - Application Analysis
    • 6.1. Global Embolization Particle Market: Application overview
      • 6.1.1. Global Embolization Particle Market revenue share, by Application, 2014 and 2024(USD Million)
    • 6.2. Trauma Embolization
      • 6.2.1. Global Embolization Particle Market for Trauma Embolization, 2015 - 2024(USD Million)
    • 6.3. Liver Tumor Embolization
      • 6.3.1. Global Embolization Particle Market for Liver Tumor Embolization, 2015 - 2024(USD Million)
    • 6.4. Prostatic Artery Embolization
      • 6.4.1. Global Embolization Particle Market for Prostatic Artery Embolization, 2015 - 2024(USD Million)
    • 6.5. Uterine Fibroid Embolization
      • 6.5.1. Global Embolization Particle Market for Uterine Fibroid Embolization, 2015 - 2024(USD Million)
    • 6.6. Others
      • 6.6.1. Global Embolization Particle Market for Others, 2015 - 2024(USD Million)
  •  
  • Chapter 7. Global Embolization Particle Market - Regional Analysis
    • 7.1. Global Embolization Particle Market: Regional overview
      • 7.1.1. Global Embolization Particle Market revenue share, by Region, 2015 and 2024
    • 7.2. North America
      • 7.2.1. North America Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
      • 7.2.2. North America Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
      • 7.2.3. North America Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.2.4.2. The U.S. Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.2.4.3. The U.S. Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.2.5.2. Rest of North America Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.2.5.3. Rest of North America Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
    • 7.3. Europe
      • 7.3.1. Europe Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
      • 7.3.2. Europe Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
      • 7.3.3. Europe Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.3.4.2. Germany Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.3.4.3. Germany Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.3.5. U.K.
        • 7.3.5.1. U.K. Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.3.5.2. U.K. Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.3.5.3. U.K. Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.3.6. France
        • 7.3.6.1. France Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.3.6.2. France Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.3.6.3. France Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.3.7.2. Rest of Europe Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.3.7.3. Rest of Europe Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
      • 7.4.2. Asia Pacific Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
      • 7.4.3. Asia Pacific Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.4.4. China
        • 7.4.4.1. China Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.4.4.2. China Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.4.4.3. China Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.4.5.2. Japan Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.4.5.3. Japan Embolization Particle Market revenue, by region, 2015 - 2024(USD Million)
      • 7.4.6. India
        • 7.4.6.1. India Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.4.6.2. India Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.4.6.3. India Embolization Particle Market revenue, by region, 2015 - 2024(USD Million)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.4.7.2. Rest of Asia Pacific Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.4.7.3. Rest of Asia Pacific Embolization Particle Market revenue, by region, 2015 - 2024(USD Million)
    • 7.5. Latin America
      • 7.5.1. Latin America Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
      • 7.5.2. Latin America Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
      • 7.5.3. Latin America Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.5.4.2. Brazil Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.5.4.3. Brazil Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
        • 7.5.5.2. Rest of Latin America Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
        • 7.5.5.3. Rest of Latin America Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Embolization Particle Market revenue, by Particle Type, 2015 - 2024(USD Million)
      • 7.6.2. The Middle East and Africa Embolization Particle Market revenue, by Application, 2015 - 2024(USD Million)
      • 7.6.3. The Middle East and Africa Embolization Particle Market revenue, by Region, 2015 - 2024(USD Million)
  •  
  • Chapter 8. Company Profile
    • 8.1. Sirtex Medical Limited
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Application portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Boston Scientific Corporation
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Application portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Merit Medical Systems
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Application portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. BTG International Ltd.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Application portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Cook Medical
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Application portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Interface BIOmaterials
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Application portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments

Methodology

Free Analysis

Embolization therapy is a minimally invasive treatment that obstructs the blood flow into one or more blood vessels feeding to the malformations, such as hypervascularized tumors and arteriovenous malformations. During the catheter embolization procedure, embolic material is injected into blood vessels to block the blood flow inside the tumor or malformation, which shrinks the malformations with time. The process of embolization treats Hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), liver cancer tumors, kidney cancer tumors, etc. Embolization therapy is performed by interventional radiologists and offers many benefits as compared to conventional surgical treatments. These benefits include minimally invasive surgeries, are highly effective in controlling bleeding, reduce trauma, faster recovery time, minimal risk of infection, no scarring, etc.

There increased prevalence of cancers and tumors is likely to drive the embolization particle market over the forecast time period. As per the National Cancer Institute 2018 Report, there were around 1,735,350 new cancer cases in the U.S. This number is expected to reach 23.6 million by 2030. Moreover, various technological advancements made in the healthcare industry are leading to various new product launches for the treatment of varied chronic conditions. However, the lack of skilled cardiologists might limit the embolization particle market in the future.

Global Embolization Particle Market

The embolization particle market is segmented on the basis of particle type and application. Based on particles type, the embolization particle market is segmented into microspheres, particles, drug-eluting beads (DEBs), and radio-embolic microspheres. Particles are expected to dominate the market in the upcoming years. Based on application, the embolization particle market is segmented into trauma embolization, liver tumor embolization, prostatic artery embolization, uterine fibroid embolization, and others. Trauma embolization is likely to grow rapidly in the estimated time period.

By region, this global market includes North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is likely to dominate the embolization particle market in the upcoming years, owing to the presence of developed countries and advanced healthcare infrastructure. Europe is expected to closely follow North America in terms of revenue. The Asia Pacific region is projected to grow rapidly owing to the presence of developing economies, such as India and China. Latin American and the Middle Eastern and African regions are expected to grow moderately in the forecast time period.

Some major players of the embolization particle market include Sirtex Medical Limited, Boston Scientific Corporation, Merit Medical Systems, BTG International Ltd., Cook Medical, and Interface BIOmaterials, among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social